Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mymd Pharmaceuticals Inc
(NQ:
MYMD
)
1.820
UNCHANGED
Last Price
Updated: 3:38 PM EDT, Jul 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mymd Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
MyMD Pharmaceuticals® Provides Dosing Update on Phase 2 Multi-Center Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan
April 12, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals® and Charles River Present Positive Data for Next Generation, Oral TNF-α Inhibitor MYMD-1® in Rheumatoid Arthritis
March 20, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 10, 2023
Via
Benzinga
MyMD Joins LOT Network To Protect Company And Shareholders From Patent Trolls
March 08, 2023
MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) has joined LOT Network, the international, non-profit community of companies working together to protect themselves against litigation brought on by patent...
Via
Benzinga
MyMD Joins LOT Network in Effort to Protect Company and Shareholders from Patent Trolls
March 08, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
March 03, 2023
Via
Benzinga
DEA Concludes MyMD's Supera-CBD Is Not A Controlled Substance Or Listed Chemical
March 02, 2023
MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) announced that the U.S. Drug Enforcement Administration has conducted a scientific review and determined that investigational cannabinoid Supera-CBD is not...
Via
Benzinga
MyMD Announces U.S. Drug Enforcement Administration (DEA) Determines Supera-CBD™ is not a Controlled Substance or Listed Chemical
March 02, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals® Announces Upcoming Presentation of Preclinical Rheumatoid Arthritis Data for Oral TNF-α Inhibitor MYMD-1® at the Society of Toxicology 2023 Annual Meeting
February 28, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Announces $15 Million Offering with Existing Investors
February 21, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
February 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 15, 2023
Via
Benzinga
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 14, 2023
Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
Via
Benzinga
Why AppTech Payments Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 31, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 30, 2023
Via
Benzinga
Why Heart Test Laboratories Are Trading Higher By 136%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 30, 2023
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 136% to $2.06 after Ascendant Capital initiated coverage on the stock with a Buy rating and a $3.30 price target.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 16, 2023
Via
Benzinga
ADDING MULTIMEDIA MyMD Pharmaceuticals® to Present Data on Oral TNF-a Inhibitor MYMD-1® at the British Society for Immunology (BSI) Congress 2022
December 06, 2022
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 23, 2022
Via
Benzinga
MyMD Pharmaceuticals® Announces Upcoming Presentation of Late-Breaking Data for MYMD-1® at the 2022 British Society for Immunology (BSI) Congress
November 17, 2022
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1® in Peer-Reviewed Journal Drug Research
November 14, 2022
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday
October 04, 2022
Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per...
Via
Benzinga
Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday
September 27, 2022
Gainers
Via
Benzinga
Why LAVA Therapeutics Shares Are Trading Higher By 97%, Here Are 49 Stocks Moving In Monday's Mid-Day Session
September 26, 2022
Gainers
Via
Benzinga
MyMD Pharmaceuticals® Provides Dosing Update on Phase 2 Multi-Center Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan
September 20, 2022
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
September 01, 2022
Gainers SenesTech (NASDAQ:SNES) stock rose 28.0% to $0.64 during Thursday's after-market session. The market value of their outstanding shares is at $7.8 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 31, 2022
Via
Benzinga
MyMD Pharmaceuticals Receives Grant From European Patent Office for Supera-CBD™ Compound
August 30, 2022
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
August 16, 2022
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.